Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for M96088105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Toronto Dominion Bank
13G/A
|
6.7% |
8/12/2026
Event 6/30/2026
|
||
| The Toronto-Dominion Bank | 6.7% | |||
| TD Securities Inc. | 0.2% | |||
| Morgan Stanley 13G | 5.4% |
8/6/2025
Event 6/30/2025
|
||
| BlackRock, Inc. 13G | 5.2% |
4/27/2026
Event 3/31/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (7) | ||||
| Menora Mivtachim Holdings Ltd 13G/A | 4.99% |
3/17/2025
Event 3/11/2025
|
||
|
Soleus Capital Master Fund, L.P.
13G/A
|
4.7% |
8/5/2025
Event 6/30/2025
|
||
| Soleus Capital Master Fund, L.P. | 4.7% | |||
| Soleus Capital, LLC | 4.7% | |||
| Soleus Capital Group, LLC | 4.7% | |||
| Soleus Capital Management, L.P. | 4.7% | |||
| Soleus GP, LLC | 4.7% | |||
| Guy Levy | 4.7% | |||
|
Paradigm Biocapital Advisors LP
13G/A
|
3.5% |
5/15/2026
Event 3/31/2026
|
||
| Paradigm BioCapital Advisors LP | 3.5% | |||
| Paradigm BioCapital Advisors GP LLC | 3.5% | |||
| Senai Asefaw, M.D. | 3.5% | |||
| Paradigm BioCapital International Fund Ltd. | 3.1% | |||
|
Adage Capital Management, L.P.
13G/A
|
2.8% |
5/12/2025
Event 3/31/2025
|
||
| Adage Capital Management, L.P. | 2.8% | |||
| Robert Atchinson | 2.8% | |||
| Phillip Gross | 2.8% | |||
|
Monograph Capital Holdings Advisors, LLC
13D/A
|
1.9% |
6/9/2025
Event 6/5/2025
|
||
| Monograph Capital Partners I, L.P. | 1.8% | |||
| Monograph Capital Partners I GenPar, LP | 1.8% | |||
| Monograph Capital Holdings Advisors, LLC | 1.8% | |||
| Fred Cohen | 1.9% | |||
| Charles Conn | 1.8% | |||
| Cowen Financial Products LLC 13G/A | 0% |
11/14/2025
Event 9/30/2025
|
||
|
RA Capital Management, L.P.
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 746 | $30.3 k |
| 2026 Q2 | 200 | 44.1 M | $1.61 B |
| 2026 Q1 | 182 | 46.4 M | $835 M |
| 2025 Q4 | 179 | 43.7 M | $1.02 B |
| 2025 Q3 | 174 | 44.5 M | $888 M |
| 2025 Q2 | 167 | 43.9 M | $602 M |
| 2025 Q1 | 146 | 41.7 M | $461 M |
| 2024 Q4 | 143 | 37.8 M | $403 M |
| 2024 Q3 | 134 | 35.2 M | $446 M |
| 2024 Q2 | 124 | 40.1 M | $673 M |
| 2024 Q1 | 120 | 28.0 M | $419 M |
| 2023 Q4 | 112 | 22.0 M | $330 M |
| 2023 Q3 | 108 | 17.7 M | $248 M |
| 2023 Q2 | 92 | 13.3 M | $138 M |
| 2023 Q1 | 71 | 12.5 M | $116 M |
| 2022 Q4 | 70 | 13.1 M | $116 M |
| 2022 Q3 | 64 | 13.3 M | $111 M |
| 2022 Q2 | 66 | 13.4 M | $109 M |
| 2022 Q1 | 85 | 14.2 M | $124 M |
| 2021 Q4 | 80 | 14.8 M | $141 M |
| 2021 Q3 | 97 | 14.1 M | $237 M |
| 2021 Q2 | 86 | 14.1 M | $215 M |
| 2021 Q1 | 93 | 14.3 M | $279 M |
| 2020 Q4 | 88 | 14.6 M | $262 M |
| 2020 Q3 | 88 | 15.0 M | $289 M |
| 2020 Q2 | 95 | 14.7 M | $382 M |
| 2020 Q1 | 85 | 14.0 M | $250 M |
| 2019 Q4 | 92 | 14.3 M | $477 M |
| 2019 Q3 | 88 | 14.6 M | $347 M |
| 2019 Q2 | 92 | 14.7 M | $527 M |
| 2019 Q1 | 78 | 13.5 M | $497 M |
| 2018 Q4 | 66 | 9.59 M | $413 M |
| 2018 Q3 | 75 | 9.95 M | $470 M |
| 2018 Q2 | 61 | 9.61 M | $483 M |
| 2018 Q1 | 44 | 9.17 M | $456 M |
| 2017 Q4 | 41 | 6.84 M | $254 M |
| 2017 Q3 | 32 | 4.61 M | $145 M |
| 2017 Q2 | 21 | 4.72 M | $85.2 M |